Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 3M COMMM · Entity 1275 | Director · Chairman of the Board | February 03, 2025 | February 18, 2025 |
| ABBOTT LABORATORIESABT · Entity 2314 | Director | September 30, 2026 | October 03, 2026 |
| Waystar Holding Corp.WAY · Entity 1420 | Director | June 03, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
3M CO
Report date February 03, 2025 · Filed February 18, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 193,397.2991 |
Reported balance
After 2025-02-03 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-02-03 · Tax withholding · Disposed 8,600 · Balance 193,397.2991 F1: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld. |
Filing footnotes · ownership attribution and instrument terms
F1: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld.
ABBOTT LABORATORIES
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 7,166 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 381 · Balance 7,166 F1: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Waystar Holding Corp.
Report date June 03, 2026 · Filed September 25, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,580 |
Reported balance
After 2026-06-03 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-06-03 · Grant · Acquired 10,446 · Balance 15,580 F1: Reflects a grant of restricted stock units ("RSUs") which vest on the earlier of (i) June 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders following the grant date. Each RSU represents a contingent right to receive one share of Common Stock upon settlement. This amended Form 4 is being filed solely to correct the number of RSUs granted from 9,303 to 10,446. F2: Includes unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") which vest on the earlier of (i) June 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders following the grant date. Each RSU represents a contingent right to receive one share of Common Stock upon settlement. This amended Form 4 is being filed solely to correct the number of RSUs granted from 9,303 to 10,446.
F2: Includes unvested RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 381 | $98.83 | $37,654.23 |
DisclosureSEC source: 0001104659-26-113280 · tm2626917-1_4seq1.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,166 Underlying: Common Shares · 381 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 21:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 416 | $90.74 | $37,747.84 |
DisclosureSEC source: 0001577544-26-000010 · form4-07012026_090744.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,746 Underlying: Common Shares · 416 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 03, 2026 Filed Sep 25, 2026 16:37 UTC Amendment | Waystar Holding Corp. WAY · Entity 1420 | GrantCommon Stock | 10,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001577544-26-000012 · wk-form4a_1790354253.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,580 F1 · shares: Reflects a grant of restricted stock units ("RSUs") which vest on the earlier of (i) June 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders following the grant date. Each RSU represents a contingent right to receive one share of Common Stock upon settlement. This amended Form 4 is being filed solely to correct the number of RSUs granted from 9,303 to 10,446. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| June 03, 2026 Filed Jun 3, 2026 22:24 UTC | Waystar Holding Corp. WAY · Entity 1420 | GrantCommon Stock | 9,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001577544-26-000008 · wk-form4_1780525449.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,437 F1 · shares: Reflects a grant of restricted stock units ("RSUs") which vest on the earlier of (i) June 1, 2027 and (ii) the first regularly scheduled annual meeting of the stockholders following the grant date. Each RSU represents a contingent right to receive one share of Common Stock upon settlement. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 23:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 2,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001577544-26-000006 · form4-04282026_110409.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,764 F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 367 | $102.67 | $37,679.89 |
DisclosureSEC source: 0001577544-26-000004 · form4-04022026_090414.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,283 Underlying: Common Shares · 367 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 301 | $125.29 | $37,712.29 |
DisclosureSEC source: 0001577544-26-000002 · form4-01052026_110105.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,882 Underlying: Common Shares · 301 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:50 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 281 | $133.94 | $37,637.14 |
DisclosureSEC source: 0001577544-25-000015 · form4-10022025_081034.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,556 Underlying: Common Shares · 281 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 271 | $136.01 | $36,858.71 |
DisclosureSEC source: 0001415889-25-018731 · form4-07012025_090714.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Shares · 271 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 16, 2025 Filed Jun 16, 2025 20:04 UTC | Waystar Holding Corp. WAY · Entity 1420 | GrantCommon Stock | 5,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-059850 · tm2518062-4_4seq1.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,134 F1 · shares: Reflects a grant of restricted stock units ("RSUs") which vest on the earlier of (i) June 4, 2026 and (ii) the first regularly scheduled annual meeting of the stockholders following the grant date. Each RSU represents a contingent right to receive one share of Common Stock upon settlement. F2 · balance_after: Includes unvested RSUs. Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 22:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 1,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-011527 · form4-04292025_100427.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,478 F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:30 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantStock Equivalent Units · Derivative | 265 | $132.65 | $35,152.25 |
DisclosureSEC source: 0001415889-25-009737 · form4-04022025_090402.xml · derivative · entry 1 Roman Michael F · CIK 0001577544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,957 Underlying: Common Shares · 265 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 18:59 UTC | 3M CO MMM · Entity 1275 | Tax withholdingCommon Stock | 9,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003130 · form4.xml · nonDerivative · entry 2 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,408.2991 F2 · shares: The number of shares withheld for taxes was estimated and will be revised by amendment if necessary. F3 · balance_after: Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan. F4 · balance_after: Includes shares acquired under 3M's General Employee Stock Purchase Plan. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 18:59 UTC | 3M CO MMM · Entity 1275 | GrantCommon Stock | 21,026.99 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-003130 · form4.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,997.2991 F1 · shares: Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2022. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified. Read SEC document |
| February 03, 2025 Filed Feb 18, 2025 16:51 UTC Amendment | 3M CO MMM · Entity 1275 | Tax withholdingCommon Stock | 8,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005167 · form4a.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,397.2991 F1 · shares: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 54,775 | $0.00 Strike: $130.14 | $0.00 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · derivative · entry 29 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,775 shares Expires 2026-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 903 | $152.43 | $137,644.29 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 28 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,895.0713 F1 · balance_after: Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 200 | $152.42 | $30,484.00 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 27 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,798.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 100 | $152.42 | $15,241.50 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 26 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,998.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 100 | $152.41 | $15,241.25 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 25 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,098.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 300 | $152.41 | $45,723.00 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 24 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,198.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 116 | $152.40 | $17,678.40 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 23 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,498.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 200 | $152.39 | $30,478.02 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 22 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,614.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,723 | $152.39 | $262,567.97 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 21 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,814.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 282 | $152.38 | $42,971.16 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 20 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,537.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 424 | $152.37 | $64,604.88 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 19 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,819.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 200 | $152.36 | $30,472.20 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 18 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,243.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,153 | $152.36 | $175,671.08 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 17 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,443.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 36 | $152.35 | $5,484.64 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 16 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,596.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,274 | $152.35 | $194,093.90 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 15 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,632.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 34 | $152.34 | $5,179.59 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 14 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,906.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,925 | $152.34 | $293,254.50 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 13 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,940.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 65 | $152.33 | $9,901.52 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 12 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,865.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,994 | $152.33 | $303,746.02 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 11 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,930.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 5 | $152.32 | $761.61 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 10 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,924.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 2,473 | $152.32 | $376,687.36 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 9 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,929.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,581 | $152.31 | $240,802.11 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 8 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,402.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 500 | $152.30 | $76,150.50 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 7 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,983.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 687 | $152.30 | $104,630.10 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 6 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,483.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 372 | $152.29 | $56,651.88 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 5 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,170.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,955 | $152.28 | $297,707.40 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 4 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,542.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 29,670 | $152.27 | $4,517,850.90 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 3 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,497.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 1,326 | $152.26 | $201,896.76 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 2 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,167.0713 Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 21:26 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionCommon Stock | 54,775 | $130.14 | $7,128,418.50 |
DisclosureSEC source: 0001127602-25-002424 · form4.xml · nonDerivative · entry 1 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,493.0713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 13:57 UTC | 3M CO MMM · Entity 1275 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 45,276 | $0.00 Strike: $146.05 | $0.00 |
DisclosureSEC source: 0001127602-25-001991 · form4.xml · derivative · entry 13 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,276 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 13:57 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 2 | $150.07 | $300.14 |
DisclosureSEC source: 0001127602-25-001991 · form4.xml · nonDerivative · entry 12 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,718.0713 F1 · balance_after: Includes dividend share equivalents, accrued quarterly, pursuant to 3M's Deferred Compensation Plan. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 13:57 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 445 | $150.06 | $66,776.70 |
DisclosureSEC source: 0001127602-25-001991 · form4.xml · nonDerivative · entry 11 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,720.0713 Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 13:57 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 100 | $150.05 | $15,005.00 |
DisclosureSEC source: 0001127602-25-001991 · form4.xml · nonDerivative · entry 10 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,165.0713 Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 13:57 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 100 | $150.05 | $15,004.50 |
DisclosureSEC source: 0001127602-25-001991 · form4.xml · nonDerivative · entry 9 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,265.0713 Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 13:57 UTC | 3M CO MMM · Entity 1275 | SaleCommon Stock | 558 | $150.04 | $83,722.32 |
DisclosureSEC source: 0001127602-25-001991 · form4.xml · nonDerivative · entry 8 Roman Michael F · CIK 0001577544 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,365.0713 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.